GRGCF yields 4.49% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, GRGCF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GRGCF + JNJ for your $10,000?
Georgia Capital PLC is a private equity and venture capital firm specializing in early stage, organic growth and acquisitions. It consider greenfields through mature stage companies. The firm typically invests in automotive retail, education services, hotels, resorts & cruise lines, restaurants, beverages, healthcare, banks, property and casualty insurance, life and health insurance, advertising, diversified REITs, water utilities, and renewable electricity. It seeks to invest in Georgia. The firm seeks board position in public portfolio companies. It exits through IPO or trade sale in five to ten years. The firm raises capital through equity and debt market transactions. Georgia Capital PLC was founded in 2018 and is based in Tbilisi, Georgia with additional office in London, Greater London and Bristol, United Kingdom. Georgia Capital PLC operates independently of BGEO Group plc as of May 29, 2018.
Full GRGCF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.